Loading stock data…
Loading stock data…
US$4.36
Get one email when SCYX crosses your level. Checked every 15 minutes during market hours.
▼ -0.12 (-2.68%)down today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
46.0
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
-0.06
Bullish momentumMACD above its signal line (-0.15).
50-day average
4.96
Price belowShort-term trend reference.
200-day average
5.86
Price belowLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Drug Manufacturers - Specialty & Generic
Scynexis, Inc. is a biotechnology company focused on developing and commercializing innovative antifungal therapies for difficult-to-treat and often life-threatening infections. Its core activity centers on a novel class of triterpenoid antifungal agents designed for both oral and intravenous administration, targeting conditions such as vulvovaginal candidiasis, invasive candidiasis, invasive aspergillosis, and other refractory invasive fungal infections. Scynexis works to address significant un…
www.scynexis.com3 strong buy · 5 buy · 1 hold · 0 sell · 0 strong sell (9 analysts, 2026-07-01)
3 strong buy · 5 buy · 1 hold · 0 sell · 0 strong sell (9 analysts, 2026-06-01)
3 strong buy · 5 buy · 1 hold · 0 sell · 0 strong sell (9 analysts, 2026-05-01)
3 strong buy · 5 buy · 1 hold · 0 sell · 0 strong sell (9 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-05-11 | -0.99 | -3.36 | ✗ Miss |
| 2026-03-04 | 1.01 | 2 | ✓ Beat |
| 2025-11-05 | -1.6 | -1.36 | ✓ Beat |
| 2025-08-13 | -1.52 | -1.12 | ✓ Beat |
| 2025-05-15 | -1.55 | -0.88 | ✓ Beat |
| 2025-03-12 | -0.16 | -0.72 | ✗ Miss |
| 2024-11-06 | -0.78 | -0.48 | ✓ Beat |
| 2024-08-08 | -1.62 | -2.4 | ✗ Miss |
Companies in the same industry, via Finnhub